Effectiveness of a web-based self-help smoking cessation intervention: protocol of a randomised controlled trial by unknown
BioMed CentralBMC Public Health
ssOpen AcceStudy protocol
Effectiveness of a web-based self-help smoking cessation 
intervention: protocol of a randomised controlled trial
Jeannet JAM Kramer*1, Marc C Willemsen2, Barbara Conijn1, Andrée J van 
Emst2, Suzanne Brunsting2 and Heleen Riper1
Address: 1Innovation Centre of Mental Health and Technology (ICOM), Trimbos Institute, PO Box 725, 3500 AS Utrecht, the Netherlands and 
2STIVORO, PO Box 16070, 2500 BB Den Haag, the Netherlands
Email: Jeannet JAM Kramer* - jkramer@trimbos.nl; Marc C Willemsen - mc.willemsen@stivoro.nl; Barbara Conijn - bconijn@trimbos.nl; 
Andrée J van Emst - avanemst@stivoro.nl; Suzanne Brunsting - sbrunsting@stivoro.nl; Heleen Riper - hriper@trimbos.nl
* Corresponding author    
Abstract
Background: Cigarette smoking is a major risk factor for many chronic and fatal illnesses.
Stopping smoking directly reduces those risks. The aim of this study is to investigate the
effectiveness of a web-based interactive self-help programme for smoking cessation, known as the
StopSite, by comparing it to an online self-help guide. Both interventions were based on cognitive-
behavioural and self-control principles, but the former provided exercises, feedback and interactive
features such as one-to-one chatrooms and a user forum, which facilitated mutual support and
experience sharing.
Methods and design: We conducted a randomised controlled trial to compare the interactive
intervention with the self-help guide. The primary outcome measure was prolonged abstinence
from smoking. Secondary outcomes were point-prevalence abstinence, number of cigarettes
smoked, and incidence of quit attempts reported at follow-up assessments. Follow-up assessments
took place three and six months after a one-month grace period for starting the intervention after
baseline. Analyses were based on intention-to-treat principles using a conservative imputation
method for missing data, whereby non-responders were classified as smokers.
Discussion: The trial should add to the body of knowledge on the effectiveness of web-based self-
help smoking cessation interventions. Effective web-based programmes can potentially help large
numbers of smokers to quit, thus having a major public health impact.
Trial registration: ISRCTN74423766
Background
Smoking heightens the risks for many diseases, such as
lung cancer [1], throat cancer [2], obstructive pulmonary
disease (COPD) [3,4]and cardiovascular diseases [5]. It
strongly increases mortality as expressed in lost life-years,
and it is the most prominent risk factor for such mortality
[6,7]. On average, smokers die about 10 years younger
than non-smokers [7]. The World Health Organization
(WHO) attributed 5.4 million deaths in 2005 to tobacco
use, a figure expected to rise to 6.4 million a year by 2015
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former smokers and increase their life expectancy. The ear-
lier they quit, the more life-years they gain [7].
In view of the pernicious consequences for smokers and
those around them and the positive effects of quitting,
smoking cessation is an important topic on the political
agenda. A current Dutch government policy aim is to
reduce the percentage of smokers in the population from
28% in 2007 to 20% in 2010 [9]. Yet smokers are known
to have a low likelihood of quitting: more than half of all
current smokers want to stop, but less than 7% of quit
attempts result in long-term abstinence. This may be
partly due to the insufficient utilisation of effective help
and support programmes [10].
STIVORO is a Dutch non-profit agency whose primary
aim is to help people stop smoking. It offers a wide range
of effective smoking cessation methods in a stepped-care
approach. Smokers are advised to begin with less inten-
sive, less costly methods (self-help guide, tailored advice)
that do not involve intervention by a professional. If these
do not work, more intensive forms of support are pro-
vided (coaching by telephone, group training, individual
counselling). At present, however, a gap still exists
between the less and the more intensive approaches to
smoking cessation. To fill that void, STIVORO developed
a web-based self-help intervention for adult smokers
known as the StopSite in 2005. It enables participants to
perform quitting activities anonymously, while interact-
ing with others if desired. This conforms to the wishes
expressed by most smokers to stop by themselves without
professional help [11,12].
A number of web-based self-help programmes for ciga-
rette smoking have become available in the past decade.
This is for good reason: the Internet makes it possible to
reach vast numbers of smokers, and the programmes
could therefore have a major positive impact on public
health. Results from several randomised trials have sug-
gested that web-based interventions can promote smok-
ing cessation, especially if the information is
appropriately tailored to the users [13-15] and frequent
automated contacts with the users are ensured [16]. All in
all, the results for web-based self-help programmes are
promising, but the number of effectiveness studies is still
limited.
The primary objective of this study was to evaluate the
effectiveness of the Dutch interactive online self-help
intervention (the StopSite) by comparing it to a self-help
guide provided on the Internet. A literature review has
shown that self-help guides can have small positive effects
on smoking cessation in comparison to no intervention
[17]. We expected that the StopSite, by virtue of its inter-
active nature, would result in higher cessation rates than
our online guide. Secondary study objectives were to
explore possible dose-response effects (whether more vis-
its to the StopSite would result in better outcomes) and
whether particular subgroups would benefit more than
others. This paper describes the trial protocol and dis-




The study is a randomised controlled trial. Participants
were randomised into two groups: an experimental group
performing the web-based interactive self-help interven-
tion and a control group accessing the online self-help
guide. The study protocol, interventions and informed
consent procedure were approved by the Dutch medical
ethics committee METiGG, Chamber North (registration
number 5209).
Inclusion and exclusion criteria
All adults aged 18 and older who were currently smoking
cigarettes or rolling tobacco, were willing to quit smoking
within three months and had Internet access were eligible
for the study. Candidates were excluded if they were
already preparing to stop smoking with the support of a
coach, a course or pharmacotherapy, or if they were
already enrolled in another smoking cessation study.
Recruitment
Candidates were recruited over a one-year period using
advertisements in daily and weekly national or regional
newspapers or on the Internet. Enrolment took place via a
website that provided information about the study and
access to the informed consent form. After returning the
signed form by post, candidates received an e-mail telling
them how to access and complete an online baseline
questionnaire. Those who failed to meet selection criteria
were then informed by e-mail.
Randomisation
The randomisation procedure was automated and was
carried out at the individual level after the baseline selec-
tion. Randomisation was stratified by gender and age
(three age groups: 18 to 29, 30 to 45, and 46 and older).
Block randomisation in blocks of two was performed to
ensure equal distribution of participants over the two
arms of the trial. Participants were informed by e-mail of
their allocation to the StopSite or the self-help guide; each
received a user name and password to log into the corre-
sponding intervention.Page 2 of 6
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The StopSite
The experimental group had access to the StopSite, which
has three components. The main component is a self-con-
trol programme consisting of exercises based on cogni-
tive-behavioural therapeutic principles. Included are
exercises to monitor smoking behaviour, set goals, sustain
motivation, analyse risk situations, consider alternative
behaviours, and deal with social pressure. The self-control
component also includes a device that counts down the
days until the chosen quit date, and afterwards displays
the number of cigarettes not smoked and the amount of
money saved. In the second component, participants can
engage in interaction with others in a users' forum or in
one-to-one chatrooms with buddies; supportive interac-
tion may motivate them to return to the site regularly. The
third component links to a large body of state-of-the-art
information about smoking cessation on the STIVORO
website http://www.stivoro.nl.
The self-help guide
The comparison group received access to a Dutch online
self-help guide developed by STIVORO for smokers who
are considering stopping. It is entitled Quit Smoking: Why
and How and includes advice on preparing to quit, infor-
mation about withdrawal symptoms, tips on how to han-
dle difficult moments, and general information about
types of support materials. The information is not person-
alised and not interactive.
Support
Both interventions were offered as stand-alone interven-
tions without support from a professional coach. During
the trial the participants were allowed to seek additional
support if they wished.
Assessments
Three assessments were made over time: a baseline assess-
ment immediately preceding randomisation and inter-
vention access, and two follow-up assessments at three
and six months following a one-month post-baseline
grace period. The grace period gave participants time to
begin the intervention. At the follow-ups, they were
invited by e-mail to complete the online assessment ques-
tionnaires, with e-mail reminders sent two weeks later if
necessary. To stimulate response, we counted every com-
pleted questionnaire as a 'ticket' for a lottery to be held at
the end of the study.
Measures
Outcomes were defined according to the guidelines pro-
vided by Mudde et al. [18,19] and Hughes et al. [20] for
evaluating smoking cessation interventions.
The primary outcome measure was prolonged abstinence
[20] in the past three months. Non-abstinence was
defined as having smoked on seven or more consecutive
days or two weekends in a row (weekend smokers). Pro-
longed abstinence was calculated for both follow-up
assessments separately and for the two follow-up periods
combined. Participants were classified as non-smokers if
they were prolonged abstinent at both follow-up assess-
ments.
The secondary outcomes were
1) point-prevalence abstinence (no smoking, not even a puff,
in the week preceding the questioning)
2) overall decrease in amounts of tobacco products smoked
(including cigars) between baseline and the follow-up
assessments.
Additional measures
At baseline, we assessed demographics and other poten-
tial confounding variables. The potential non-demo-
graphic confounding variables as defined by Mudde et al
[18] were:
- current stage of change on a readiness-to-change scale.
Possible stages for potential quitters are the immotive (no
intention to quit), preparation and contemplation stages;
the act of quitting is followed by the action stage (less than
six months of abstinence) and maintenance stage (six or
more months of abstinence)
- attitude towards quitting: expectations regarding effects
of smoking cessation in terms of health improvement,
sociability, lung cancer risk, relaxation problems, with-
drawal symptoms, health of others, and boredom
- social influences on quitting: encouragement by others
to quit (5 items) and presence of smokers in daily envi-
ronment (5 items)
- self-efficacy expectations (abilities to refrain from smok-
ing in difficult circumstances, 6 items).
Other potential confounders were:
- the level of nicotine dependence as measured by the
number of cigarettes smoked per day in combination with
time to first cigarette (Heaviness of Smoking Index) [21].
- expectations that a web-based self-help programme
would be helpful to stop smoking (question constructed
by the researchers).Page 3 of 6
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professional or other help or support materials (t1 and t2)
and participants' evaluation of their assigned intervention
(t1). A tracking tool automatically recorded logins to the
interventions.
Sample size
The sample size was based on the expected contrast
between the experimental group (StopSite) and the com-
parison group (self-help guide) in their rates of prolonged
abstinence. We expected 5.5% of the comparison group
[22] and 11% of the experimental group to report pro-
longed abstinence at 6-month follow-up. Based on a
power of 80% using a two-tailed test with an alpha of .05,
at least 353 participants were needed in each condition.
Adjusting for an expected 40% dropout at 6 months, we
needed a total of 1,104 participants. Sample size was cal-
culated with Stata 7.0/SE.
Statistical analysis
We used t-tests, chi-square tests and logistic regression (p
< .10) to assess whether the randomisation had resulted in
two comparable groups at baseline and whether differen-
tial loss to follow-up had occurred. We then performed
intention-to-treat (ITT) analyses including all randomised
participants and classifying those not responding to fol-
low-up questionnaires as smokers (the worst-case sce-
nario); this is a conservative way of handling non-
response. We also conducted analyses including only the
participants that actually used the assigned intervention.
The use of both interventions was monitored by the track-
ing tool that recorded participant logins; 'use of the inter-
vention' was defined as visiting the StopSite or opening
the self-help guide at least once.
Differences between groups at follow-up on dichotomous
outcome measures (prolonged abstinence, point-preva-
lence abstinence and quit attempts) were analysed using
chi-square tests or logistic regression, depending on the
need to adjust for possible confounders. A linear risk
model was used to obtain the risk difference (RD). The
number needed to treat (NNT) was calculated as the
inverse of the RD (number needed to treat stands for the
number of people who must receive the intervention in
order for one person to successfully stop smoking).
Between-group differences in tobacco use reduction from
baseline to t1 and from baseline to t2 were analysed in lin-
ear regression models. Magnitudes of intervention effect
were estimated using Cohen's d [23]. Effect sizes were first
calculated for each condition separately by subtracting the
mean posttest score from the mean pretest score and
dividing the result by the standard deviation at pretest.
The effect size of the comparison group was then sub-
tracted from that of the experimental group. A difference
in d of 0.5 would indicate that the experimental group
mean was half a standard deviation greater than the con-
trol group mean. Values of d from 0.56 to 1.2 may be
regarded as large, from 0.33 to 0.55 as moderate, and
from 0 to 0.32 as small [24].
To identify subgroups that particularly benefited from the
intervention, we examined the influence that interaction
between the smokers' baseline characteristics and the
intervention itself might have had on treatment response
[25]. In a logistic regression model, the primary outcome
(prolonged abstinence) was regressed on dummy-coded
baseline characteristics (age and gender), the main inter-
vention effect and the characteristic-by-intervention inter-
action term. It is the interaction term that is of interest
here: it reflects any potential added benefit that the Stop-
Site might have for participants with specific attributes.
To detect possible dose-response relationships, we used a
logistic regression model to regress the primary outcome
(prolonged abstinence) at t2 on the number of times
logged in to the StopSite; only the respondents ran-
domised to the StopSite (the experimental group) were
included in the dose-response analyses. Tests were con-
ducted at α = .05 (two-sided) with 95% confidence inter-
vals. Analyses were performed with SPSS version 15.1.
Discussion
This article describes the protocol of a randomised con-
trolled trial that compared two self-help smoking cessa-
tion interventions delivered via the Internet. The primary
aim was to assess the effectiveness of StopSite, a Dutch
cognitive-behavioural self-help site with interactive ele-
ments but without involvement of a coach or therapist.
The comparison intervention was a Dutch self-help guide
entitled Quit Smoking: Why and How. Both interventions
were developed by STIVORO, a Dutch organisation on
smoking and health. We expected the StopSite to double
the effect of the self-help guide in terms of tobacco absti-
nence. We did not include a no-treatment control group
because of the greater potential for contamination by
external interventions; no-treatment controls might be
more likely to seek help elsewhere during the study.
Participants were recruited through advertisements in
national and regional newspapers and through banners
on the Internet. As a consequence, the study is likely to
have included disproportionate numbers of smokers with
higher motivations to quit; generalisability is therefore
restricted to smokers who are already in the preparation or
contemplation stage of change. This methodological
weakness is also a potential strength, as it probably makes
the trial sample a closer reflection of the population being
targeted by the intervention: people who are already moti-
vated to stop smoking, but who need some support inPage 4 of 6
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ence of a coach or therapist.
The primary outcome measure was prolonged abstinence
from smoking in the six months after the intervention,
allowing for a one-month grace period after baseline for
performing the intervention. This is a widely accepted,
albeit minimum, time frame for smoking cessation trials
[26]. The primary outcome, six-month abstinence, was
estimated using abstinence measures at two assessment
times (three and six months); it was therefore not an ideal
measure of prolonged abstinence. We did not perform
biochemical verification of self-reported abstinence. That
is consistent with recommendations by the Subcommittee
on Biochemical Verification of the Society for Research on
Nicotine and Tobacco (SRNT), which suggest that bio-
chemical validation may not be necessary or advisable in
studies like ours with limited face-to-face contact and with
postal, telephone or Internet data collection [27].
The entire trial was conducted via the Internet with the
exception of the signed informed consent document that
was returned by post. There was no face-to-face or tele-
phone contact between participants and researchers dur-
ing the trial. The screening and baseline questionnaires,
randomisation outcomes, and invitations and reminders
for online follow-up assessments were all sent by e-mail.
Such an approach ensures a low threshold for study par-
ticipation, but makes the study susceptible to higher attri-
tion rates due to participant dropout or non-utilisation of
the intervention [28].
The blinding of respondents to experimental conditions
was not feasible because of the behavioural nature of both
interventions. The participants were aware of the interven-
tion to which they were receiving access, but unaware of
whether it was the experimental or comparison interven-
tion. No explicit descriptions of the interventions were
given before randomisation, thus reducing the chance
that participants would feel more disappointed or satis-
fied with their intervention in relation to the other.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
JK was the principal investigator and wrote the manu-
script. MW and AvE obtained funding for the study. HR
served as an adviser. BC carried out the recruitment and
data collection. SB and all other authors contributed to
the manuscript and have approved the final version.
Acknowledgements
We are grateful to Michael Dallas for the English language edit. The study 
was funded by a research grant from ZonMw, the Netherlands Organisa-
tion for Health Research and Development, grant no. 62000008.
References
1. Williams MD, Sandler AB: The epidemiology of lung cancer.
Cancer Treat Res 2001, 105:31-52.
2. Blot WJ: Esophageal cancer trends and risk factors.  Semin
Oncol 1994, 21:403-410.
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global
strategy for the diagnosis, management, and prevention of
chronic obstructive pulmonary disease. NHLBI/WHO Glo-
bal Initiative for Chronic Obstructive Lung Disease (GOLD)
Workshop summary.  Am J Respir Crit Care Med 2001,
163:1256-1276.
4. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist
AS, et al.: Effects of smoking intervention and the use of an
inhaled anticholinergic bronchodilator on the rate of decline
of FEV1. The Lung Health Study.  JAMA 1994, 272:1497-1505.
5. Deckers JW, Kromhout D: De invloed van leefstijl en voeding op
hartziekten.  Het bulletin 2005, 36:126-130.
6. Hoeymans N, Hoogenveen RT, Poos MJJC: Wat is de bijdrage van
risicofactoren?  Volksgezondheid Toekomst Verkenning, Nationaal
Kompas Volksgezondheid 2006 [http://www.nationaalkompas.nl].
Bilthoven: RIVM
7. Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to
smoking: 50 years' observations on male British doctors.
BMJ: British Medical Journal 2004, 328:1519-1528.
8. Mathers CD, Loncar D: Projections of global mortality and bur-
den of disease from 2002 to 2030.  PLoS Med 2006, 3:e442.
9. Ministerie van Volksgezondheid Welzijn en Sport.  In Nota
Kiezen voor gezond leven [Opting for a healthy life. Public health policy in
the Netherlands 2007 2010] Den Haag, VWS; 2006. 
10. Ministerie van Volksgezondheid Welzijn en Sport.  In Nation-
aal Programma Tabaksontmoediging Den Haag, VWS; 2006. 
11. Frisby G, Bessell TL, Borland R, Anderson JN: Smoking cessation
and the Internet: a qualitative method examining online con-
sumer behavior.  J Med Internet Res 2002, 4:E8.
12. Williams GC, McGregor HA, Sharp D, Levesque C, Kouides RW,
Ryan RM, et al.: Testing a self-determination theory interven-
tion for motivating tobacco cessation: supporting autonomy
and competence in a clinical trial.  Health Psychol 2006,
25:91-101.
13. Borland R, Balmford J, Hunt D: The effectiveness of personally
tailored computer-generated advice letters for smoking ces-
sation.  Addiction 2004, 99:369-377.
14. Strecher VJ, Shiffman S, West R: Randomized controlled trial of
a web-based computer-tailored smoking cessation program
as a supplement to nicotine patch therapy.  Addiction (Abingdon)
2005, 100:682-688.
15. Swartz LH, Noell JW, Schroeder SW, Ary DV: A randomised con-
trol study of a fully automated internet based smoking ces-
sation programme.  Tob Control 2006, 15:7-12.
16. Brendryen H, Kraft P: Happy ending: a randomized controlled
trial of a digital multi-media smoking cessation intervention.
Addiction 2008, 103:478-484.
17. Lancaster T, Stead LF: Self-help interventions for smoking ces-
sation.  Cochrane Database Syst Rev 2005:CD001118.
18. Mudde AN, Willemsen MC, Kremers S, De Vries H: Meetinstrumenten
voor onderzoek naar roken en stoppen met roken. [Measurements for
research on smoking and smoking cessation] Den Haag: Stivoro; 2000. 
19. Mudde AN, Willemsen MC, Kremers S, De Vries H: Meetinstrumenten
voor onderzoek naar roken en stoppen met roken (rev.) [Measurements for
research on smoking and smoking cessation] Den Haag: Stivoro; 2006. 
20. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan
GE: Measures of abstinence in clinical trials: issues and rec-
ommendations.  Nicotine & Tobacco Research: Official Journal Of The
Society For Research On Nicotine And Tobacco 2003, 5:13-25.
21. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J:
Measuring the heaviness of smoking: using self-reported
time to the first cigarette of the day and number of ciga-
rettes smoked per day.  British Journal Of Addiction 1989,
84:791-799.
22. Willemsen MC, Wagena EJ, van Schayck CP: The efficacy of smok-
ing cessation methods available in the Netherlands: a sys-
tematic review based on Cochrane data [De effectiviteit van
stoppen-met-rokenmethoden die in Nederland beschikbaar
zijn: een systematische review op basis van Cochrane-
gegevens].  Nederlands Tijdschrift Voor Geneeskunde 2003,
147:922-927.Page 5 of 6
(page number not for citation purposes)
BMC Public Health 2009, 9:32 http://www.biomedcentral.com/1471-2458/9/32Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
23. Cohen J: Statistical power analysis for the behavioral sciences 2nd edition.
Hillsdale, NJ: Erlbaum; 1988. 
24. Lipsey MW, Wilson DB: The efficacy of psychological, educa-
tional, and behavioral treatment. Confirmation from meta-
analysis.  The American Psychologist 1993, 48:1181-1209.
25. Cronbach LJ, Snow RE: Aptitudes and instructional methods. A Handbook
for research on interactions New York: Irvington Publishers; 1977. 
26. West R, Hajek P, Stead L, Stapleton J: Outcome criteria in smok-
ing cessation trials: proposal for a common standard.  Addic-
tion 2005, 100:299-303.
27. SRNT subcommittee on biological markers: Biochemical verifica-
tion of tobacco use and cessation.  Nicotine Tob Res 2002,
4:149-159.
28. Eysenbach G: The law of attrition.  Journal Of Medical Internet
Research 2005, 7:e11.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/9/32/prepubPage 6 of 6
(page number not for citation purposes)
